The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain injury.
2023/50/E/NZ7/00586
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ5_03: Patogeneza chorób człowieka
- NZ4_07: Neurofizjologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński, Collegium Medicum
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 11
Call
SONATA BIS 13 – announced on 2023-06-19
- Amount awarded
- 4 326 486 PLN
- Project start date
- 2024-11-28
- Project end date
- 2029-11-27
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.